Edico Genome was a company based in San Diego, California that sells a product for processing DNA sequencing data. The company was acquired by Illumina in May 2018.
Edico Genome iswas a company based in San Diego, California that sells a product for processing DNA sequencing data. The company was acquired by Illumina in May 2018.
A company developing bioinformatics processor chip that aids in DNA analysis
The company was founded in 2013 by Pieter Van Rooyen, Robert McMillen, and Michael Ruehle.
Edico Genome was a San Diego-based company that developed a bioinformatics processor chip and platform, Dragen, to aid in DNA analysis. The Dragen platform was designed to allow for fast, accurate analysis of reams of raw data generated with each human gene sequencing.
Edico Genome announced $10 million in venture capital financing in July 2014, which was led by Qualcomm Ventures and included Axon Ventures and Gregory T. Lucier, the former chairman and CEO of Life Technologies.
The company was founded in 2013 by Pieter Van Rooyen, Robert McMillen, and Michael Ruehle.
Edico's DRAGEN processor is claimed to reduce the time needed to analyze a whole human genome, from 24 hours to 18 minutes. DRAGEN was announced in October 2014. Edico Genome made its first sale of DRAGEN in September 2014 to Sequenom, a San Diego company focused on non-invasive prenatal testing.
The processor is claimed to reduce the time needed to analyze a whole human genome, from 24 hours to 18 minutes. DRAGEN was announced in October 2014. Edico Genome made its first sale of DRAGEN in September 2014 to Sequenom, a San Diego company focused on non-invasive prenatal testing.
On May 15, 2018, Illumina announced that it had acquired Edico Genome.
February 7, 2024